Literature DB >> 2199848

The occurrence of oligoclonal IgG in tears from patients with MS and systemic immune disorders.

M Mavra1, E J Thompson, J Nikolic, A Krunic, J Ranin, Z Levic, G Keir, R Luxton, B D Youl.   

Abstract

Using isoelectric focusing (IEF) and immunoperoxidase staining of proteins transferred to nitrocellulose membranes, we have examined the IgG band pattern in tears and matched serum and CSF specimens of 28 patients with MS, 4 patients with optic neuritis (ON), 30 individuals with systemic, inflammatory, or other neurologic diseases, and 5 patients with tension headache. We found no evidence of positive oligoclonal IgG in tears in any MS or ON patients, while 10 out of 16 cases with systemic immune disorders or infections of the CNS had positive tear oligoclonal bands. We are thus not able to support the hypothesis that tears from MS patients reveal abnormalities in their humoral immune response.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2199848     DOI: 10.1212/wnl.40.8.1259

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  4 in total

1.  Iso-electric focusing of aqueous humour IgG in multiple sclerosis.

Authors:  C H Hawkes; E J Thompson; G Keir; J Elston; M Hawkes; R Lamb; S Ruben
Journal:  J Neurol       Date:  1994-06       Impact factor: 4.849

2.  Diagnostic biomarkers in tear fluid: from sampling to preanalytical processing.

Authors:  Franziska Bachhuber; André Huss; Makbule Senel; Hayrettin Tumani
Journal:  Sci Rep       Date:  2021-05-12       Impact factor: 4.379

Review 3.  Tear fluid biomarkers in ocular and systemic disease: potential use for predictive, preventive and personalised medicine.

Authors:  Suzanne Hagan; Eilidh Martin; Amalia Enríquez-de-Salamanca
Journal:  EPMA J       Date:  2016-07-13       Impact factor: 6.543

4.  Investigation of Oligoclonal IgG Bands in Tear Fluid of Multiple Sclerosis Patients.

Authors:  Martin W Hümmert; Ulrich Wurster; Lena Bönig; Philipp Schwenkenbecher; Kurt-Wolfram Sühs; Sascha Alvermann; Stefan Gingele; Thomas Skripuletz; Martin Stangel
Journal:  Front Immunol       Date:  2019-05-17       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.